Baird Upgrades Teladoc (TDOC) to Outperform

(Updated - January 14, 2019 3:46 AM EST)

(updated to add analyst comment)

Baird analyst Matthew Gillmor upgraded Teladoc (NYSE: TDOC) from Neutral to Outperform with a price target of $80.00.

The analyst comments "With the stock down ~40% off 2018 highs we now think valuation is more attractive. Additionally, we think there will be several positive catalysts during 1H19 including: (1) potential for guidance to be in-line/above Street estimates; (2) Medicare Advantage sales ahead of June biding deadlines; and (3) positive announcements re: UNH penetration."

For an analyst ratings summary and ratings history on Teladoc click here. For more ratings news on Teladoc click here.

Shares of Teladoc closed at $55.47 yesterday.

You May Also Be Interested In

• Deutsche Bank Upgrades Target Hospitality (TH) to Buy
• Andersen Group launches secondary offering of 4.28M shares
• JPMorgan Upgrades BWP Trust (BWP:AU) to Neutral